NeuroBo Pharmaceuticals, Inc.·4

Dec 4, 5:12 PM ET

Tursi James Patrick 4

4 · NeuroBo Pharmaceuticals, Inc. · Filed Dec 4, 2023

Insider Transaction Report

Form 4
Period: 2023-12-01
Transactions
  • Award

    Common Stock

    2023-12-01+25,00025,000 total
  • Award

    Common Stock

    2023-12-01+7,15732,157 total
Footnotes (3)
  • [F1]Represents a grant of restricted stock units ("RSUs") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan.
  • [F2]50% of the RSUs immediately vested on the grant date, and the remainder will vest in two equal installments on each subsequent anniversary of the grant date, subject to continuing service.
  • [F3]Vests on the earlier of December 1, 2024 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT